Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/24/23
End: 01/17/24
Due: 01/17/25
Phase: N/A
Priority: Normal
Start: 05/24/21
End: 01/20/22
Due: 01/20/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose | NCT06092788 | ATXA Therapeutics Limited | user2@example.com | None | 2023-11-24 | 2024-01-17 | 2025-01-17 | - | - | 2025-07-14 |
| Safety, Tolerability and Pharmacokinetics of NTP42:KVA4 | NCT04919863 | ATXA Therapeutics Limited | user2@example.com | None | 2021-05-24 | 2022-01-20 | 2023-01-20 | - | - | 2025-07-14 |